The (PIVOTAL) Study

NCT ID: NCT00444821

Last Updated: 2021-10-11

Study Results

Results available

Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.

View full results

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

TERMINATED

Clinical Phase

NA

Total Enrollment

728 participants

Study Classification

INTERVENTIONAL

Study Start Date

2005-03-31

Study Completion Date

2010-01-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The purpose of this study is to compare endovascular repair using any FDA approved Medtronic AAA Stent Graft System versus surveillance in subjects with smaller abdominal aortic aneurysms (AAA)(4-5CM), with respect to AAA rupture and AAA related deaths.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

ABDOMINAL AORTIC ANEURYSMS

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Surveillance

Group Type NO_INTERVENTION

No interventions assigned to this group

Early Endovascular Repair

Group Type EXPERIMENTAL

AneuRx AAA stent graft / Talent AAA stent graft

Intervention Type DEVICE

Catheter based stent graft inserted to seal off an abdominal aortic aneurysm

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

AneuRx AAA stent graft / Talent AAA stent graft

Catheter based stent graft inserted to seal off an abdominal aortic aneurysm

Intervention Type DEVICE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* 40 to 90 years of age
* Meet all indications for use as stated in the Medtronic Vascular AAA Endograft Instructions for Use
* Maximum aneurysm diameter of 4-5cm
* If female patient with child bearing potential, must have a documented negative pregnancy test within seven(7)days prior to inclusion
* Patient is willing and able to comply with the specified follow-up evaluation
* Life expectancy at least 3 years

Exclusion Criteria

* Meet any of the Contraindications stated in the Medtronic Vascular AAA Endograft instructions for Use
* Known co-existing condition with a life expectancy of less than 3 years
* Major surgical or interventional procedure (vascular and/or non-vascular)within 30 days prior to study enrollment
* Subjects enrolled in another clinical trial or anticipated to be included into a trial, which may interfere with this study, or subjects already enrolled in this trial before.
* Planned conduit procedure for introduction of endograft
Minimum Eligible Age

40 Years

Maximum Eligible Age

90 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

The Cleveland Clinic

OTHER

Sponsor Role collaborator

Medtronic Cardiovascular

INDUSTRY

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Kenneth Ouriel, MD

Role: PRINCIPAL_INVESTIGATOR

New York Presbyterian Hospital

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

University of Alabama

Birmingham, Alabama, United States

Site Status

Tucson Vascular Surgery

Tucson, Arizona, United States

Site Status

University of Arizona - UMC

Tucson, Arizona, United States

Site Status

VA Hospital

Little Rock, Arkansas, United States

Site Status

Palomar Hospital

Escondido, California, United States

Site Status

Long Beach VA Healthcare System

Long Beach, California, United States

Site Status

UCLA Medical Center

Los Angeles, California, United States

Site Status

University of Southern California

Los Angeles, California, United States

Site Status

Stanford University VA

Palo Alto, California, United States

Site Status

UC Davis Medical Center

Sacramento, California, United States

Site Status

Stanford University Medical Center

Stanford, California, United States

Site Status

University of Florida

Gainesville, Florida, United States

Site Status

Mayo Clinic

Jacksonville, Florida, United States

Site Status

Leesburg Regional Medical Center

Leesburg, Florida, United States

Site Status

University of South Florida

Tampa, Florida, United States

Site Status

St. Joseph's Research Institute

Atlanta, Georgia, United States

Site Status

Wellstar Clinical Trials

Marietta, Georgia, United States

Site Status

University of Chicago

Chicago, Illinois, United States

Site Status

Decatur Memorial Hospital

Decatur, Illinois, United States

Site Status

Adventist Midwest Health

Hinsdale, Illinois, United States

Site Status

Southern Illinois University

Springfield, Illinois, United States

Site Status

Cardiac Surgery Associates

Munster, Indiana, United States

Site Status

Iowa Heart Center

Des Moines, Iowa, United States

Site Status

Tri-State Vascular Group

Ashland, Kentucky, United States

Site Status

Vascular Surgery Associates

Baton Rouge, Louisiana, United States

Site Status

Vascular Surgery Associates

Bel Air, Maryland, United States

Site Status

Brigham and Women's Hospital

Boston, Massachusetts, United States

Site Status

Massachusetts General Hospital

Boston, Massachusetts, United States

Site Status

University of Michigan

Ann Arbor, Michigan, United States

Site Status

Michigan Vascular Center

Flint, Michigan, United States

Site Status

William Beaumont Hospital

Royal Oak, Michigan, United States

Site Status

Mayo Clinic

Rochester, Minnesota, United States

Site Status

South Central Regional Medical Center

Laurel, Mississippi, United States

Site Status

St. John's Regional Medical Center

Joplin, Missouri, United States

Site Status

Albany Medical Center

Albany, New York, United States

Site Status

Westchester Medical Center

Hawthorne, New York, United States

Site Status

Columbia University Medical Center

New York, New York, United States

Site Status

Staten Island University Hospital

Staten Island, New York, United States

Site Status

Mission / St. Joseph Hospital

Asheville, North Carolina, United States

Site Status

University of North Carolina

Chapel Hill, North Carolina, United States

Site Status

Presbyterian Hospital

Charlotte, North Carolina, United States

Site Status

East Carolina University

Greenville, North Carolina, United States

Site Status

Wake Forest University School of Medicine

Winston-Salem, North Carolina, United States

Site Status

The Lindner Clinical Trials Center

Cincinnati, Ohio, United States

Site Status

Cleveland Clinic Foundation

Cleveland, Ohio, United States

Site Status

Ohio State University

Columbus, Ohio, United States

Site Status

The Dayton Heart Center

Dayton, Ohio, United States

Site Status

Jobst Vascular Center

Toledo, Ohio, United States

Site Status

Oregon

Medford, Oregon, United States

Site Status

Lehigh Valley Hospital

Allentown, Pennsylvania, United States

Site Status

UPMC Vascular Surgery

Pittsburgh, Pennsylvania, United States

Site Status

North Central Heart Institute

Sioux Falls, South Dakota, United States

Site Status

University Surgical Associates

Chattanooga, Tennessee, United States

Site Status

Baptist Memorial Hospital

Memphis, Tennessee, United States

Site Status

St. Thomas Hospital

Nashville, Tennessee, United States

Site Status

Vanderbilt University Medical Center

Nashville, Tennessee, United States

Site Status

Methodist Dallas Medical Center

Dallas, Texas, United States

Site Status

UT Southwestern Medical Center

Dallas, Texas, United States

Site Status

Baylor College of Medicine

Houston, Texas, United States

Site Status

Wilford Hall Medical Center

Lackland Air Force Base, Texas, United States

Site Status

Texas

Temple, Texas, United States

Site Status

University of Virginia

Charlottesville, Virginia, United States

Site Status

Sentara Heart Hospital

Norfolk, Virginia, United States

Site Status

Sacred Heart Medical Center

Spokane, Washington, United States

Site Status

Wisconsin Heart / Meriter Hospital

Madison, Wisconsin, United States

Site Status

Countries

Review the countries where the study has at least one active or historical site.

United States

References

Explore related publications, articles, or registry entries linked to this study.

Eisenstein EL, Davidson-Ray L, Edwards R, Anstrom KJ, Ouriel K. Economic analysis of endovascular repair versus surveillance for patients with small abdominal aortic aneurysms. J Vasc Surg. 2013 Aug;58(2):302-10. doi: 10.1016/j.jvs.2013.01.038. Epub 2013 Apr 4.

Reference Type DERIVED
PMID: 23562339 (View on PubMed)

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

VS-2005-01

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.